• FirefoxInstall the new Firefox »
  •  Dow Up 0.21% Nasdaq Up 0.32%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    428.95 Up 15.91(3.85%) Mar 5, 4:00PM EST
    Add to Portfolio
    Prev Close:413.04
    Open:414.93
    Bid:425.01 x 500
    Ask:432.00 x 100
    1y Target Est:444.45
    Beta:0.69
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:414.21 - 430.67
    52wk Range:269.50 - 437.64
    Volume:1,166,024
    Avg Vol (3m):841,870
    Market Cap:43.70B
    P/E (ttm):139.72
    EPS (ttm):3.07
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    REGNUp 3.85%43.70B
    AMGNUp 0.26%121.11B
    NVSDown 0.09%237.34B
    RHHBYDown 1.07%N/A

    Key Statistics

    Forward P/E (1 yr):34.82
    P/S (ttm):14.93
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :10.74
    Quarterly EPS Est (Mar-15) :2.70
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):2.12

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback